|
8RLT
TCR in complex with HLA-E*01:03 bound to HBV envelope 371-379 index peptide
Deposited 2024-01-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain C
427–435(9 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;20% (w/v) PEG 3350, 100 mM BIS-TRIS propane pH 8.5, 200 mM sodium sulfate
|
Resolution 2.25 Å
R-free 0.252
|
|
8RLT
TCR in complex with HLA-E*01:03 bound to HBV envelope 371-379 index peptide
Deposited 2024-01-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain H
427–435(9 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;20% (w/v) PEG 3350, 100 mM BIS-TRIS propane pH 8.5, 200 mM sodium sulfate
|
Resolution 2.25 Å
R-free 0.252
|
|
8RLU
TCR in complex with HLA-E*01:03 bound to HBV envelope 371-379 S3N peptide
Deposited 2024-01-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain C
427–435(9 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;20% (w/v) PEG 3350, 100 mM BIS-TRIS propane pH 8.5, 200 mM sodium sulfate
|
Resolution 2.35 Å
R-free 0.261
|
|
8RLU
TCR in complex with HLA-E*01:03 bound to HBV envelope 371-379 S3N peptide
Deposited 2024-01-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain H
427–435(9 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;20% (w/v) PEG 3350, 100 mM BIS-TRIS propane pH 8.5, 200 mM sodium sulfate
|
Resolution 2.35 Å
R-free 0.261
|
|
8RLV
TCR in complex with HLA-E*01:03 bound to HBV envelope 371-379 L6I peptide
Deposited 2024-01-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain C
427–435(9 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;20% (w/v) PEG 3350, 100 mM BIS-TRIS propane pH 8.5, 200 mM sodium sulfate
Collection Temp: 100
|
Resolution 2.61 Å
R-free 0.251
|
|
8RLV
TCR in complex with HLA-E*01:03 bound to HBV envelope 371-379 L6I peptide
Deposited 2024-01-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain H
427–435(9 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;20% (w/v) PEG 3350, 100 mM BIS-TRIS propane pH 8.5, 200 mM sodium sulfate
Collection Temp: 100
|
Resolution 2.61 Å
R-free 0.251
|